145 related articles for article (PubMed ID: 7179649)
1. [Prodectin treatment of partial hearing loss as a result of atherosclerosis].
Smirnova NA; Timakov VA; Mikushkin MK
Vestn Otorinolaringol; 1982; (6):53-6. PubMed ID: 7179649
[No Abstract] [Full Text] [Related]
2. The use of prodectin in the treatment of cerebral arteriosclerosis and its complications.
Abrányi I; Máté
Ther Hung; 1976; 24(1):20-3. PubMed ID: 790631
[No Abstract] [Full Text] [Related]
3. Clinical and laboratory examinations with Prodectin.
Bédi J; Kosztovics A; Pálos LA
Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
[No Abstract] [Full Text] [Related]
4. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
5. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
Hunyi L
Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
[No Abstract] [Full Text] [Related]
6. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Hunyi L
Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
[No Abstract] [Full Text] [Related]
7. [Use of prodectin in pulmonary tuberculosis].
Safarov RN; Makinskiĭ AI
Vrach Delo; 1981 Nov; (11):83-4. PubMed ID: 7342450
[No Abstract] [Full Text] [Related]
8. [Use of the antikinin preparation prodectin in the complex treatment of pulmonary tuberculosis patients].
Keleberda KIa; Svistunova AS; Kaminskaia GO; Kordonskaia VM
Probl Tuberk; 1982 Oct; (10):42-5. PubMed ID: 7178102
[No Abstract] [Full Text] [Related]
9. [Pyridinolcarbamate treatment of ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
[No Abstract] [Full Text] [Related]
10. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
Roztocil K; Oliva I; Linhart J; Prerovský I; Modr Z
Cas Lek Cesk; 1976 Aug; 115(33-34):1051-5. PubMed ID: 975177
[No Abstract] [Full Text] [Related]
11. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
[No Abstract] [Full Text] [Related]
12. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Pola P
J Pharm Sci; 1975 Jan; 64(1):261-9. PubMed ID: 1094102
[No Abstract] [Full Text] [Related]
13. The effect of Prodectin (pyridinolcarbamate) treatment of the circulation rate in obliterating arterial diseases of the lower extremities.
Fényes G; Gótzy G; Fehrentheil L
Ther Hung; 1975; 23(2):64-66. PubMed ID: 1188705
[No Abstract] [Full Text] [Related]
14. [Clinical and rheoencephalographical evaluation of prodectin in the treatment of cerebral arteriosclerosis].
Wysocka-Bakowska MM
Neurol Neurochir Pol; 1981; 15(4):431-36. PubMed ID: 7035991
[TBL] [Abstract][Full Text] [Related]
15. [Prodectin in the treatment of viral hepatitis].
Kozhukhova EA; Iakushin AI; Zakharova VI; Mebel' BD; Larionov GM
Sov Med; 1983; (10):96-7. PubMed ID: 6658556
[No Abstract] [Full Text] [Related]
16. [Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Valiensi M; Riboli E; Lombardi M
Minerva Cardioangiol; 1976 Feb; 24(2):148-54. PubMed ID: 1256654
[No Abstract] [Full Text] [Related]
17. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
Rakhmatov AB; Bilash NV
Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
[No Abstract] [Full Text] [Related]
18. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
Fisanovich TI; Tolstova LG
Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
[No Abstract] [Full Text] [Related]
19. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
[No Abstract] [Full Text] [Related]
20. Attempts to delay progression in occlusive atherosclerosis.
Terry EN; Rouen LR; Clasuss RH; Katz MC; Redisch W
Ann N Y Acad Sci; 1976; 275():379-85. PubMed ID: 1070279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
